2013China Modern DoctorRequires access

Clinical efficacy of benazepril combined with prostaglandin El for the treatment of diabetic nephropathy

Tao Zhu

Open publisher page 0 citations

Abstract

Objective To observe clinical efficacy of benazepril combined with prostaglandin E1 on treating diabetic nephropathy(DN).Methods A total of 50 patients with DN were enrolled and randomLy divided into combination treatment group(n = 25) and benazepril treatment group(n = 25),and the changes of urine protein and renal function were observed.Results After 4 weeks treatment,24 h urine protein level and 24 h urinary microalbumin excretive rate of combination treatment group were significantly decreased than that before treatment(P 0.05).After 8 weeks treatment,24 h urine protein level and 24 h urinary microalbumin excretive rate of two groups were significantly decreased than that before treatment(P 0.05),and the combination treatment group were decreased more significantly than benazepril treatment group(P 0.05).Conclusion Benazepril combined with prostaglandin E1 treatment is an ideal treatment for DN and worthy of clinical use.

About this research paper

What this paper is about

Objective To observe clinical efficacy of benazepril combined with prostaglandin E1 on treating diabetic nephropathy(DN).Methods A total of 50 patients with DN were enrolled and randomLy divided into combination treatment group(n = 25) and benazepril treatment group(n = 25),and the changes of urine protein and renal function were observed.Results After 4 weeks treatment,24 h urine protein level and 24 h urinary microalbumin excretive rate of combination treatment group were significantly decreased than that before treatment(P 0.05).After 8 weeks treatment,24 h urine protein level and 24 h urinary microalbumin excretive rate of two groups were significantly decreased than that before treatment(P 0.05),and the combination treatment group were decreased more significantly than benazepril treatment group(P 0.05).Conclusion Benazepril combined with prostaglandin E1 treatment is an ideal treatment for DN and worthy of clinical use.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe clinical efficacy of benazepril combined with prostaglandin E1 on treating diabetic nephropathy(DN).Methods A total of 50 patients with DN were enrolled and randomLy divided into combination treatment group(n = 25) and benazepril treatment group(n = 25),and the changes of urine protein and renal function were observed.Results After 4 weeks treatment,24 h urine protein level and 24 h urinary microalbumin excretive rate of combination treatment group were significantly decreased than that before treatment(P 0.05).After 8 weeks treatment,24 h urine protein level and 24 h urinary microalbumin excretive rate of two groups were significantly decreased than that before treatment(P 0.05),and the combination treatment group were decreased more significantly than benazepril treatment group(P 0.05).Conclusion Benazepril combined with prostaglandin E1 treatment is an ideal treatment for DN and worthy of clinical use.

Key concepts: Benazepril, Medicine, Diabetic nephropathy, Urology, Urine, Urinary system, Prostaglandin, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical efficacy of benazepril combined with prostaglandin El for the treatment of diabetic nephropathy — Research Paper | ScholarLens